Zika Virus Vaccines


The live-attenuated vaccine is developed for the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos.  The understanding of flavivirus particle structure, the definition of E dimers as the key antigenic target, and a deep understanding of neutralization mechanisms help to develop the vaccine.


    Related Conference of Zika Virus Vaccines

    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria
    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    Zika Virus Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in